Important: All continuing pharmacy education (CPE) credit(s) must be claimed within 60 days of enrolling in an online activity.   Learn More Learning activities are available for a specific time after the activity has been accessed or opened. Be sure to know the close date of your activities. Each activity shows a "Close Date" in the far right side next to the activity title. All activities must be completed before the close date or they will expire and you will not be able to claim CPE credit.  Click here for instructions on how to get started.                                                                                                                                                                                               

Main Catalog

Found 103
Sort by
Home Study Programs
Member Free
Non-Member $30.00

Rare Disease Therapies: Management Strategies to Pipeline Implications for Health Plans

Contact Hours: 1.5. The drug pipeline contains over 560 therapies in development for rare diseases.
Orphan Disease
Home Study Programs
Member $15.00
Non-Member $30.00

Real-World Experience Managing Orphan Drugs Across Pharmacy and Medical Benefits

Contact Hours: 1.25. Recently approved drugs for orphan diseases have annual costs ranging from $90,000 to over $1 million, while also having variable value propositions.
Orphan Disease
Home Study Programs
Member Free
Non-Member $30.00

Role of the Managed Care Pharmacist in Using Pharmacoeconomic Analyses in Formulary Decision-Making

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2016.
Drug Pricing
Home Study Programs
Member Free
Non-Member $30.00

Something Old, Something New: Medicare Audits 2017 and Beyond

Contact Hours: 1.5. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Nexus 2016.
CMS
Home Study Programs
Member $39.00
Non-Member $79.00

Specialty Connect 2018 Bundle!

A dynamic, cutting-edge look at evolving standards of care and emerging therapeutic options for hemophilia— designed for and with industry leaders, experts and Managed care pharmacists operating in the fast-growing specialty sector.
Hemophilia
Home Study Programs
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development

Contact Hours: 1.5. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty Pharmacy
Home Study Programs
Member $15.00
Non-Member $30.00

Specialty Pharmaceuticals in Development 2018

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty Pharmacy
Home Study Programs
Member Free
Non-Member Free

Spinal Muscular Atrophy: Patient Outcomes and Cost Considerations Home Study

Contact Hours: 1.0. Spinal muscular atrophy (SMA) is a rare, genetic, neuromuscular disease that causes progressive muscle weakness and deterioration. SMA is categorized into four types, depending on the severity of the disease, and each type presents its own unique clinical management challenges.
Free Home Study
Home Study Programs
Member Free
Non-Member $30.00

Spotlight on the Oncology Pipeline

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | With the recent emphasis and success of immune checkpoint inhibitors for the treatment of various tumor types, it is tempting to assume that the oncology pipeline exclusively focuses on immunotherapies.
Oncology
Home Study Programs
Member Free
Non-Member $30.00

Strategic Management of High-Cost Generics: Outcomes of a Novel Clinical Program

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2016.
Brand and Generic Drugs